Aurobindo Pharma plans to launch 50-60 products in US in FY21
Aurobindo Pharma's US business posted a growth of 27 per cent year-on-year to Rs 11,484 crore in FY20.
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.